Moderna
MRNA
#1219
Rank
A$23.98 B
Marketcap
$62.32
Share price
1.58%
Change (1 day)
-58.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$23.98 Billion

As of January 2025 Moderna has a market cap of A$23.98 Billion. This makes Moderna the world's 1219th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$23.98 B-3.4%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Jan 22nd, 2025 the market cap of Moderna was reported to be:

A$23.60 Billion
by Yahoo Finance info icon info icon
A$23.60 Billion
by CompaniesMarketCap info icon info icon
A$23.60 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.12 B-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$388.70 B 1,520.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.32 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$55.80 B 132.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$319.27 B 1,231.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$4.18 B-82.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$561.70 B 2,242.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.74 B-80.21%๐Ÿ‡บ๐Ÿ‡ธ USA